Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
Author(s) -
ElBattrawy Ibrahim,
Lan Huan,
Cyganek Lukas,
Maywald Lasse,
Zhong Rujia,
Zhang Feng,
Xu Qiang,
Lee Jihyun,
Duperrex Eliane,
Hierlemann Andreas,
Saguner Ardan M.,
Duru Firat,
Kovacs Boldizsar,
Huang Mengying,
Liao Zhenxing,
Albers Sebastian,
Müller Jonas,
Dinkel Hendrik,
Rose Lena,
Hohn Alyssa,
Yang Zhen,
Qiao Lin,
Li Yingrui,
Lang Siegfried,
Kleinsorge Mandy,
Mügge Andreas,
Aweimer Assem,
Fan Xuehui,
Diecke Sebastian,
Akin Ibrahim,
Li Guang,
Zhou Xiaobo
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.646
Subject(s) - short qt syndrome , medicine , induced pluripotent stem cell , brugada syndrome , qt interval , sudden cardiac death , sudden death , amiodarone , cardiology , herg , long qt syndrome , gene , potassium channel , genetics , biology , embryonic stem cell , atrial fibrillation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom